Tumor antigen LRRC15 impedes adenoviral infection: implications for virus-based cancer therapy
about
Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11.Augmentation of adenovirus 5 vector-mediated gene transduction under physiological pH conditions by a chitosan/NaHCO3 solution.Oncogene-induced sensitization to chemotherapy-induced death requires induction as well as deregulation of E2F1.Accelerated parallel algorithm for gene network reverse engineering.
P2860
Tumor antigen LRRC15 impedes adenoviral infection: implications for virus-based cancer therapy
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Tumor antigen LRRC15 impedes a ...... for virus-based cancer therapy
@ast
Tumor antigen LRRC15 impedes a ...... for virus-based cancer therapy
@en
Tumor antigen LRRC15 impedes a ...... for virus-based cancer therapy
@en-gb
Tumor antigen LRRC15 impedes a ...... for virus-based cancer therapy
@nl
type
label
Tumor antigen LRRC15 impedes a ...... for virus-based cancer therapy
@ast
Tumor antigen LRRC15 impedes a ...... for virus-based cancer therapy
@en
Tumor antigen LRRC15 impedes a ...... for virus-based cancer therapy
@en-gb
Tumor antigen LRRC15 impedes a ...... for virus-based cancer therapy
@nl
prefLabel
Tumor antigen LRRC15 impedes a ...... for virus-based cancer therapy
@ast
Tumor antigen LRRC15 impedes a ...... for virus-based cancer therapy
@en
Tumor antigen LRRC15 impedes a ...... for virus-based cancer therapy
@en-gb
Tumor antigen LRRC15 impedes a ...... for virus-based cancer therapy
@nl
P2860
P921
P356
P1433
P1476
Tumor antigen LRRC15 impedes a ...... for virus-based cancer therapy
@en
P2093
Jim O'Prey
P2860
P304
P356
10.1128/JVI.02273-07
P407
P577
2008-06-01T00:00:00Z